Quest Partners LLC decreased its holdings in TriMas Co. (NASDAQ:TRS – Free Report) by 66.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,325 shares of the industrial products company’s stock after selling 21,942 shares during the period. Quest Partners LLC’s holdings in TriMas were worth $289,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in the stock. Impax Asset Management Group plc increased its stake in TriMas by 216.4% in the 3rd quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company’s stock valued at $10,467,000 after buying an additional 280,431 shares during the period. Kennedy Capital Management LLC increased its stake in shares of TriMas by 197.8% in the first quarter. Kennedy Capital Management LLC now owns 273,200 shares of the industrial products company’s stock worth $7,303,000 after acquiring an additional 181,447 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of TriMas by 2.3% in the first quarter. Vanguard Group Inc. now owns 4,358,524 shares of the industrial products company’s stock worth $116,503,000 after acquiring an additional 100,068 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its position in TriMas by 1.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,145,236 shares of the industrial products company’s stock valued at $80,298,000 after purchasing an additional 51,701 shares during the last quarter. Finally, First Eagle Investment Management LLC boosted its position in TriMas by 26.2% during the second quarter. First Eagle Investment Management LLC now owns 240,006 shares of the industrial products company’s stock valued at $6,135,000 after purchasing an additional 49,800 shares during the last quarter. 99.42% of the stock is owned by hedge funds and other institutional investors.
TriMas Trading Up 0.1 %
TriMas stock opened at $26.99 on Tuesday. TriMas Co. has a one year low of $22.45 and a one year high of $28.51. The company’s fifty day moving average price is $26.34 and its two-hundred day moving average price is $25.86. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. The company has a market capitalization of $1.09 billion, a price-to-earnings ratio of 42.17 and a beta of 0.66.
TriMas Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, November 12th. Investors of record on Tuesday, November 5th were paid a $0.04 dividend. The ex-dividend date was Tuesday, November 5th. This represents a $0.16 dividend on an annualized basis and a yield of 0.59%. TriMas’s payout ratio is presently 25.00%.
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on TRS. BWS Financial reaffirmed a “buy” rating and set a $40.00 price target on shares of TriMas in a research note on Tuesday, November 5th. StockNews.com upgraded shares of TriMas from a “sell” rating to a “hold” rating in a research note on Wednesday, November 13th.
Check Out Our Latest Stock Analysis on TriMas
TriMas Company Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Further Reading
- Five stocks we like better than TriMas
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- What Does Downgrade Mean in Investing?
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Consumer Discretionary Stocks Explained
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.